Beta Bionics Files 8-K on Financials
Ticker: BBNX · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1674632
| Field | Detail |
|---|---|
| Company | Beta Bionics, Inc. (BBNX) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Beta Bionics dropped an 8-K on March 25th detailing their financials. Check it out.
AI Summary
Beta Bionics, Inc. filed an 8-K on March 25, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 11 Hughes, Irvine, California.
Why It Matters
This filing provides investors with crucial updates on Beta Bionics' financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual events or risks.
Key Players & Entities
- Beta Bionics, Inc. (company) — Registrant
- March 25, 2025 (date) — Date of earliest event reported
- 11 Hughes, Irvine, California 92618 (address) — Principal Executive Offices
- 001-42491 (filing_id) — SEC File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Beta Bionics, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed as of March 25, 2025.
What is Beta Bionics, Inc.'s principal executive office address?
Beta Bionics, Inc.'s principal executive office is located at 11 Hughes, Irvine, California 92618.
What is the SEC file number for Beta Bionics, Inc.?
The SEC file number for Beta Bionics, Inc. is 001-42491.
What is the SIC code for Beta Bionics, Inc.?
The Standard Industrial Classification (SIC) code for Beta Bionics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Beta Bionics, Inc. (BBNX).